Comparing 3D Pharmacophore Triplets and 2D Fingerprints for Selecting Diverse Compound Subsets

Journal of Chemical Information and Computer Sciences

Volumn 39, Issue 6, 1999, Pages 1211-1225

  Matter, Hans ^a   Pötter, Thorsten ^b  

^a SANOFI   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001027028     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci980185h     Document Type: Article

References (65)

1. Ferguson, A. M.; Patterson, D. E.; Garr, C.; Underiner, T. Designing Chemical Libraries for Lead Discovery. J. Biomol. Screen. 1996, 1, 65-73.
2. (a) Moos, W. H.; Green, G. D.; Pavia, M. R. Recent Advances in the Generation of Molecular Diversity. Annu. Rep. Med. Chem. 1993, 28, 315-324.
3. (b) Brown, R. D. Descriptors for diversity analysis. Perspect. Drug Discuss. Des. 1997, 718, 31-49.
4. (c) Martin, Y. C.; Brown, R. D.; Bures, M. G. Quantifying Diversity. In Combinatorial Chemistry and Molecular Diversity in Drug Discovery; Gordon, E. M., Kerwin, J. F., Jr., Eds.; Wiley: New York, 1998; pp 369-385.
5. (d) Bures, M. G.; Martin, Y. C. Computational methods in molecular diversity and combinatorial chemistry. Curr. Opin. Chem. Biol. 1998, 2, 376-380.
6. (e) Willett, P., Ed. Computational Methods for the Analysis of Molecular Diversity, Vol. 8; Kluwer/ESCOM: Dordrecht, The Netherlands, 1997.
7. Pötter, T.; Matter, H. Random or Rational Design? Evaluation of Diverse Compound Subsets from Chemical Structure Databases. J. Med. Chem. 1998, 41, 478-488.
8. (a) Patterson, D. E.; Cramer, R. D.; Ferguson, A. M.; Clark, R. D.; Weinberger, L. E. Neighborhood Behavior: A Useful Concept for Validation of "Molecular Diversity" Descriptors. J. Med. Chem. 1996, 39, 3049-3059.
9. (b) Brown, R. D.; Bures, M. G.; Martin, Y. C. Similarity and cluster analysis applied to molecular diversity, American Chemical Society Meeting, Anaheim, CA, 1995, COMP3.
10. (c) Brown, R. D.; Martin, Y. C. Use of Structure-Activity Data to Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection. J. Chem. Inf. Comput. Sci. 1996, 36, 572-584.
11. Matter, H. Selecting Optimally Diverse Compounds from Structure Databases: A Validation Study of Two-Dimensional and Three-Dimensional Molecular Descriptors. J. Med. Chem. 1997, 40, 1219-1229.
12. Martin, E. J.; Blaney, J. M.; Siani, M. A.; Spellmeyer, D. C.; Wong, A, K.; Moos, W. H. Measuring Diversity: Experimental Design of Combinatorial Libraries for Drug Discovery. J. Med. Chem. 1995, 38, 1431-1436.
13. Molecular Similarity in Drug Design; Dean, P. M., Ed.; Chapman and Hall: London, 1995.
14. Maggiora, G. M.; Johnson, M. A. Concepts and Applications of Molecular Similarity; John Wiley & Sons: New York, 1990; pp 99-117.
15. (a) Gallop, M. A.; Barrett, R. W.; Dower, W. J.; Fodor, S. P. A.; Gordon, E. M. Applications of Combinatorial Technologies to Drug Discovery. 1. Background and Peptide Combinatorial Libraries. J. Med. Chem. 1994, 37, 1233-1251.
16. (b) Gordon, E. M.; Barrett, R. W.; Dower, W. J.; Fodor, S. P. A.; Gallop, M. A. Applications of Combinatorial Technologies to Drug Discovery. 2. Combinatorial Organic Synthesis, Library Screening Strategies, and Future Directions. J. Med. Chem. 1994, 37, 1385-1399.
17. (c) Madden, D.; Krchnak, V.; Lebl, M. Synthetic combinatorial libraries: Views on techniques and their applications. Persp. Drug Discovery Des. 1995, 2, 269-285.
18. (d) Ellman, J. A. Design, Synthesis and Evaluation of Small-Molecule Libraries. Acc. Chem. Res. 1996, 29, 132-143.
19. (e) Gordon, E. M.; Gallop, M. A.; Patel, D. V. Strategy and Tactics in Combinatorial Organic Synthesis. Application to Drug Discovery. Acc. Chem. Res. 1996, 29, 144-154.
20. Van Drie, J. H.; Lajiness, M. S. Approaches to virtual library design. Drug Discuss. Today 1998, 3, 274-283.
21. (a) Todeschini, R.; Lasagni M.; Marengo, E. New Molecular Descriptors for 2D and 3D Structures. Theory. J. Chemom. 1994, 8, 263-272.
22. (b) Todeschini, R.; Gramatica, P.; Provenzani, R.; Marengo, E. Weighted holistic invariant molecular descriptors. Part 2. Theory development and applications on modeling physicochemical properties of polyaromatic hydrocarbons. Chemom. Intell. Lab. Syst. 1995, 27, 221-229.
23. (c) Todeschini, R.; Bettiol, C.; Giurin, G.; Gramatica, P.; Miana, P.; Argese, E. Modeling and prediction by using WHIM descriptors in QSAR studies: Submitochondrial particles (SMP) as toxicity biosensors of chlorphenols. Chemosphere 1996, 33, 71-79.
24. Cramer, R. D.; Patterson, D. E.; Bunce, J. E. Comparative Molecular Field Analysis (CoMFA). 1. Effect of Shape on Binding of. Steroids to Carrier Proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
25. Clark, M.; Cramer, R. D.; Jones, D. M.; Patterson, D. E.; Simeroth, P. E. Comparative Molecular Field Analysis (CoMFA). 2. Towards its use with 3D-Structural Databases. Tetrahedron. Comput. Methodol. 1990, 3, 47-59.
26. (a) Moreau, G.; Broto, P. The Autocorrelation of a Topological Structure: A New Molecular Descriptor. Nouv. J. Chim. 1980, 4, 359-360.
27. (b) Moreau, G.; Broto, P. Autocorrelation of Molecular Structures, Application to SAR Studies. Nouv. J. Chim. 1980, 4, 757-764.
28. (c) Broto, P.; Moreau, G.; Vandycke, C. Molecular Structures: Perception, Autocorrelation Descriptor and SAR Studies. Eur. J. Med. Chem. 1984, 19, 66-70.
29. Wagener, M.; Sadowski, J.; Gasteiger J. Autocorrelation of Molecular Surface Properties for Molecular Corticosteroid Binding Globulin and Cytosolic Ah Receptor Activity by Neural Networks. J. Am. Chem. Soc. 1995, 117, 7769-7775.
30. (a) Cramer, R. D.; Clark, R. D.; Patterson, D. E.; Ferguson, A. M. Bioisosterism as a Molecular Diversity Descriptor: Steric Fields of Single "Topomeric" Conformers. J. Med. Chem. 1996, 39, 3060-3069.
31. (b) Clark, R. D.; Ferguson, A. M.; Cramer, R. D. Bioisosterism and molecular diversity. Perspect. Drug Discovery Des. 1998, 9-11 (3D QSAR in Drug Design: Ligand/Protein Interactions and Molecular Similarity), 213-224.
32. Ashton, M. J.; Jaye, M. C., Mason, J. S. New Perspectives in Lead Generation. D. Evaluating Molecular Diversity. Drug Discovery Today 1996, 2, 71-78.
33. Pickett, S. D.; Mason, J. S.; McLay, I. M. Diversity Profiling and Design Using 3D Pharmacophores: Pharmacophore-Derived Queries (PDQ). J. Chem. Inf. Comput. Sci. 1996, 36, 1214-1223.
34. Brown, R. D.; Martin, Y. C. Use of Structure-Activity Data To Compare Structure Based Clustering Methods and Descriptors for Use in Compound Selection. J. Chem. Inf. Comput. Sci. 1996, 36, 572-584.
35. Brown, R. D.; Martin, Y. C. The Information Content of 2D and 3D Structural Descriptors Relevant to Ligand-Receptor Binding. J. Chem. Inf. Comput. Sci. 1997, 37, 1-9.
36. Davies, K. Using pharmacophore diversity to select molecules to test from commercial catalogs, including DIVERSet and HTS Chemicals. In Molecular Diversity and Combinatorial Chemistry: Libraries and Drug Discovery; Chaiken, I. M., Janda, K. D., Eds.; American Chemical Society: Washington, D.C., 1996; pp 309-316.
37. ChemDiverse, available from Chemical Design Ltd.: Oxon, U.K., 1996.
38. Selector, Tripos, Inc.: St. Louis, MO, 1996.
39. Mason, J. S. New Pharmacophore-Based Methods for Molecular Similarity Applications and to Design Diverse and Biased Libraries. J. Mol. Graph. 1998, 16, 51.
40. (a) Willett, P. Similarity and Clustering in Chemical Information Systems; Research Studies Press: Letchworth, U.K., 1987.
41. (b) Willett, P.; Winterman, V. A. Comparison of Some Measures for the Determination of Intermolecular Structural Similarity. Quant. Struct.-Activ. Relat. 1986, 5, 18-25.
42. Holliday, J. D.; Ranade, S. S.; Willett, P. A Fast Algorithm for Selecting Sets of Dissimilar Molecules from Large Chemical Data-bases. Quant. Struct.-Activ. Relat. 1996, 14, 501-506.
43. Matter, H.; Lassen, D. Compound Libraries for Lead Discovery. Chim. Oggi 1996, 14, 9-15.
44. SYBYL Molecular Modelling Package, Version 6.3; Tripos, Inc.: St. Louis, MO, 1996.
45. UNITY Chemical Information Software, Version 2.6; Tripos, Inc.: St. Louis, MO, 1996.
46. Ash, S.; Cline, M. A.; Homer, W.; Hurst, T.; Smith, G. B. SYBYL Line Notation (SLN): A Versatile Language for Chemical Structure Representation. J. Chem. Inf. Comput. Sci. 1997, 37, 71-79.
47. Kriuth, D. E. Sorting and searching; Addison-Wesley: Reading, MA.
48. For more details to compute fingerprints, see e.g.: UNITY Chemical Information Software, Version 2.6; Tripos: Inc.: St. Louis, MO, 1996.
49. Martin, Y. C.; Bures, M. G.; Danaher, E. A.; DeLazzer, J.; Lico, I.; Pavlik, P. A. A fast new approach to pharmacophore mapping and its application to doparninergic and benzodiazepine agonists. J. Comput.-Aided Mol. Des. 1993, 7, 83-102.
50. Pearlman, R. S.; Balducci, R.; Rusinko, A.; Skell, J. M.; Smith, K. N. CONCORD, program version 3.2.1; Tripos., Inc.: St. Louis, MO, 1996.
51. Hurst, T. Flexible 3D Searching: The Directed Tweak Technique. J. Chem. Inf. Comput. Sci. 1994, 34, 190-196.
52. Lajiness, M.; Johnson, M. A.; Maggiora, G. M. Implementing Drug Screening Programs using Molecular Similarity Methods. In QSAR: Quantitative Structure-Activity Relationships in Drug Design; Fauchere, J. L., Ed.; Alan R. Liss Inc.: New York, 1989; pp 173-176.
53. Taylor, R. Simulation Analysis of Experimental Design Strategies for Screening Random Compounds as Potential New Drugs and Agrochemicals. J. Chem. Inf. Comput. Sci. 1995, 35, 59-67.
54. Lajiness, M. S. Dissimilarity-based compound selection techniques. Perspect. Drug Discuss. Des. 1997, 7/8, 65-84.
55. Holliday, J. D.; Ranade, S. S., Willett, P. A fast algorithm for selecting sets of dissimilar molecules from large chemical databases. Quant. Struct.-Act. Relat. 1995, 14, 501-506.
56. Snarey, M.; Terrett, N. K.; Willett, P.; Wilton, D. J. Comparison of algorithms for dissimilarity-based compound selection. J. Mol. Graph. 1997, 15, 372-385.
57. Murtagh, F. Multidimensional Clustering Algorithms. COMPSTAT Lectures. 4. Physica-Verlag: Vienna, 1985.
58. Barnard, J. M.; Downs, G. M. Clustering of Chemical Structures on the Basis of Two-Dimensional Similarity Measures. J. Chem. Inf. Comput. Sci. 1992, 32, 644-649.
59. Index Chemical Database-Subset from 1993; Institute for Scientific Information, Inc. (ISI): Philadelphia, PA, 1993.
60. Sheridan, R. P.; Nachbar, R. B.; Bush, B. L. Extending the trend vector: The trend matrix and sample-based partial least squares. J. Comput.-Aided Mol. Des. 1994, 8, 323-340.
61. DePriest, S. A.; Mayer, D.; Naylor, C. B.; Marshall, G. R. 3D-QSAR of Angiotensin-Converting Enzyme and Thermolysin Inhibitors: A Comparison of CoMFA Models Based on Deduced and Experimentally Determined Active Site Geometries. J. Am. Chem. Soc. 1993, 115, 5372-5384.
62. Wold, S.; Eriksson, L.; Hellberg, S.; Jonsson, J.; Sjöström, M.; Skagerberg, B.; Wikström, C. Principal property values for six nonnatural amino acids and their application to a structure-activity relationship for oxytocin peptide analogues. Can. J. Chem. 1987, 65, 1814-1820.
63. Cushman, D. W.; Cheung, H.-S.; Sabo, E. F.; Ondetti, M. A. 1981, in Proceedings of the A. N. Richards Symposium, May 8-9, 1980; Horowitz, Z. P., Ed.; Urban & Schwarzenberg: Baltimore, MD, 1980; pp 3-25.
64. Pearlman, R. S.; Smith, K. M. Novel software tools for chemical diversity. Perspect. Drug Discovery Des. 1998, 9-11, 339-353.
65. Martin, Y. C.; Brown, R. D.; Danaher, E. A.; DeLazzer, J., Lico, I. 3D descriptors that outperform substructures in diversity analysis. Book of Abstracts, 214th ACS National Meeting, Las Vegas, NV, 1997; American Chemical Society: Washington, DC, 1997; CINF-046.